TY - JOUR
T1 - Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease
AU - Dransfield, Mark T.
AU - Davis, Jennifer J.
AU - Gerald, Lynn B.
AU - Bailey, William C.
PY - 2006/6
Y1 - 2006/6
N2 - Background: Although chronic obstructive pulmonary disease (COPD) has been considered a disease of Caucasian men, recent data show mortality rising faster among women and African-Americans. Some have suggested these groups are more susceptible to tobacco smoke. We examined this issue in our own population of COPD patients. Methods: Beginning in March 2003 we prospectively developed a COPD research database to facilitate recruitment for clinical trials. Enrollees are recruited from clinics and paid advertising and their demographics, medical/smoking histories, and spirometric data are recorded. We examined the smoking histories and pulmonary function of enrollees over 45, with {greater than or slanted equal to}20 pack-years of smoking, FEV1/FVC (forced expiratory volume forced vital capacity) <0.70, and a race-adjusted post-bronchodilator FEV1<80%. The primary outcome was the loss of lung function per pack-year smoked, or Susceptibility Index (SI), calculated using the formula: (% predicted FEV1-100)/pack-years. Results: A total of 585 patients enrolled during the study period and 330 met our inclusion criteria. Caucasians were older than African-Americans (63 vs. 58, P = 0.0003) and had more pack-years of smoking (57 vs. 43, P = 0.0003). There were no differences in lung function or bronchodilator reversibility among the racial or gender subgroups. Caucasians had less loss of lung function per pack-year smoked than African-Americans ( SI = - 1.02 % vs. -1.34%, P = 0.007) and men less than women ( SI = - 0.98 % vs. -1.21%, P = 0.001). Caucasian males appeared relatively protected from tobacco smoke ( SI = - 0.93 %), while African-American women appeared most susceptible ( SI = - 1.42 %). Conclusions: There are important differences in racial and gender susceptibility to tobacco smoke among patients with COPD. African-American females appear to be at highest risk and may benefit most from smoking cessation.
AB - Background: Although chronic obstructive pulmonary disease (COPD) has been considered a disease of Caucasian men, recent data show mortality rising faster among women and African-Americans. Some have suggested these groups are more susceptible to tobacco smoke. We examined this issue in our own population of COPD patients. Methods: Beginning in March 2003 we prospectively developed a COPD research database to facilitate recruitment for clinical trials. Enrollees are recruited from clinics and paid advertising and their demographics, medical/smoking histories, and spirometric data are recorded. We examined the smoking histories and pulmonary function of enrollees over 45, with {greater than or slanted equal to}20 pack-years of smoking, FEV1/FVC (forced expiratory volume forced vital capacity) <0.70, and a race-adjusted post-bronchodilator FEV1<80%. The primary outcome was the loss of lung function per pack-year smoked, or Susceptibility Index (SI), calculated using the formula: (% predicted FEV1-100)/pack-years. Results: A total of 585 patients enrolled during the study period and 330 met our inclusion criteria. Caucasians were older than African-Americans (63 vs. 58, P = 0.0003) and had more pack-years of smoking (57 vs. 43, P = 0.0003). There were no differences in lung function or bronchodilator reversibility among the racial or gender subgroups. Caucasians had less loss of lung function per pack-year smoked than African-Americans ( SI = - 1.02 % vs. -1.34%, P = 0.007) and men less than women ( SI = - 0.98 % vs. -1.21%, P = 0.001). Caucasian males appeared relatively protected from tobacco smoke ( SI = - 0.93 %), while African-American women appeared most susceptible ( SI = - 1.42 %). Conclusions: There are important differences in racial and gender susceptibility to tobacco smoke among patients with COPD. African-American females appear to be at highest risk and may benefit most from smoking cessation.
KW - Chronic obstructive pulmonary disease
KW - Race
KW - Smoking
UR - http://www.scopus.com/inward/record.url?scp=33646058257&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33646058257&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2005.09.019
DO - 10.1016/j.rmed.2005.09.019
M3 - Article
C2 - 16236491
AN - SCOPUS:33646058257
SN - 0954-6111
VL - 100
SP - 1110
EP - 1116
JO - Respiratory Medicine
JF - Respiratory Medicine
IS - 6
ER -